Cargando…
Imaging subclinical coronary atherosclerosis to guide lipid management, are we there yet?
Atherosclerotic cardiovascular disease risk (ASCVD) is an ongoing epidemic, and lipid abnormalities are its primordial cause. Most individuals suffering a first ASCVD event are previously asymptomatic and often do not receive preventative therapies. The cornerstone of primary prevention has been the...
Autores principales: | Piña, Pamela, Lorenzatti, Daniel, Paula, Rita, Daich, Jonathan, Schenone, Aldo L, Gongora, Carlos, Garcia, Mario J, Blaha, Michael J, Budoff, Matthew J, Berman, Daniel S, Virani, Salim S, Slipczuk, Leandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813535/ https://www.ncbi.nlm.nih.gov/pubmed/36619296 http://dx.doi.org/10.1016/j.ajpc.2022.100451 |
Ejemplares similares
-
Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017) -
Ten things to know about ten imaging studies: A preventive cardiology perspective (“ASPC top ten imaging”)
por: Bays, Harold E., et al.
Publicado: (2021) -
Exercise and Coronary Atherosclerosis: Observations, Explanations, Relevance, and Clinical Management
por: Aengevaeren, Vincent L., et al.
Publicado: (2020) -
Leveling the playing field: The utility of coronary artery calcium scoring in cardiovascular risk stratification in South Asians
por: Agarwala, Anandita, et al.
Publicado: (2022) -
Stroke in young adults: Current trends, opportunities for prevention and pathways forward
por: Yahya, Tamer, et al.
Publicado: (2020)